MyFinsight
Home
Blog
About
Marketable securities
$256,004K
(266.01%↑ Y/Y)
Cash and cash
equivalents
$67,836K
(-36.82%↓ Y/Y)
Prepaid expenses and
other current assets
$5,188K
(-21.95%↓ Y/Y)
Property and equipment,
gross
$9,774K
(3.68%↑ Y/Y)
Total current assets
$329,028K
(78.86%↑ Y/Y)
Right-of-use assets -
operating lease
$14,993K
(-9.80%↓ Y/Y)
Property and equipment,
net
$2,201K
(-23.15%↓ Y/Y)
Other long-term
assets
$1,139K
(515.68%↑ Y/Y)
Restricted cash and
deposits
$768K
(0.00%↑ Y/Y)
Lessaccumulated depreciation
$7,573K
(15.39%↑ Y/Y)
Total assets
$348,129K
(70.32%↑ Y/Y)
Total liabilities and
stockholders' equity
$348,129K
(70.32%↑ Y/Y)
Total stockholders'
equity
$315,267K
(80.54%↑ Y/Y)
Total liabilities
$32,862K
(10.39%↑ Y/Y)
Accumulated deficit
-$559,740K
(-30.56%↓ Y/Y)
Treasury stock, at cost,
6,922,870 shares held at...
$39,093K
Accumulated other
comprehensive loss
-$670K
(-2780.00%↓ Y/Y)
Additional paid-in capital
$914,769K
(51.62%↑ Y/Y)
Total current
liabilities
$19,560K
(31.70%↑ Y/Y)
Long-term operating lease
liability
$13,302K
(-10.82%↓ Y/Y)
Common stock, 0.00001
par value,...
$1K
Accrued expenses and
other current...
$14,014K
(35.14%↑ Y/Y)
Short-term operating lease
liability
$3,292K
(203.00%↑ Y/Y)
Accounts payable
$2,254K
(75.27%↑ Y/Y)
Back
Back
Balance Sheet
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA)
source: myfinsight.com